Galapagos NV
GLPG
#4558
Rank
NZ$3.76 B
Marketcap
NZ$57.14
Share price
0.00%
Change (1 day)
35.73%
Change (1 year)

Market capitalization of Galapagos NV (GLPG)

Market cap: NZ$3.76 Billion

As of January 2026 Galapagos NV has a market cap of NZ$3.76 Billion. This makes Galapagos NV the world's 4558th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Galapagos NV from 2008 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.76 B0.18%
2025NZ$3.75 B17.82%
2024NZ$3.18 B-24.69%
2023NZ$4.23 B-7.96%
2022NZ$4.60 B-13.95%
2021NZ$5.34 B-40.4%
2020NZ$8.97 B-55.26%
2019NZ$20.05 B168.08%
2018NZ$7.48 B10.65%
2017NZ$6.76 B57.19%
2016NZ$4.30 B19.44%
2015NZ$3.60 B394.46%
2014NZ$0.72 B-4.5%
2013NZ$0.76 B11.02%
2012NZ$0.68 B50.31%
2011NZ$0.45 B-17.12%
2010NZ$0.55 B57.13%
2009NZ$0.35 B98.18%
2008NZ$0.17 B

End of Day market cap according to different sources

On Jan 21st, 2026 the market cap of Galapagos NV was reported to be:

NZ$3.76 Billion
by Nasdaq info icon info icon
NZ$3.76 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
NZ$479.08 B 12,624.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$896.39 B 23,707.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$191.42 B 4,984.06%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
NZ$651.95 B 17,215.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ$0.18 B-95.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$358.60 B 9,424.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$61.49 B 1,533.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GSK plc
GSK
NZ$165.79 B 4,303.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$473.63 B 12,479.30%๐Ÿ‡บ๐Ÿ‡ธ USA